+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

PK guided multi-dose, tolerance and safety of E-7869 in prostate cancer patients



PK guided multi-dose, tolerance and safety of E-7869 in prostate cancer patients



Proceedings of the American Association for Cancer Research Annual Meeting (41): 609




(PDF emailed within 1 workday: $29.90)

Accession: 035454608

Download citation: RISBibTeXText


Related references

Multi-dose phase I-II trial of E-7869 in prostate cancer patients Safety and time to PSA progression. Proceedings of the American Association for Cancer Research Annual Meeting 42: 142, 2001

Multi-dose Phase IIa trial of MPC-7869 in prostate cancer patients with increasing prostate specific antigen. Proceedings of the American Association for Cancer Research Annual Meeting 43: 749, 2002

Safety and tolerance of transrectal ultrasound-guided (TRUS) biopsy in the diagnosis of prostate cancer. Radiologia 49(6): 417-423, 2007

Re: Safety of ultrasound-guided transrectal extended prostate biopsy in patients receiving low-dose aspirin. International Braz J Urol 36(4): 497-498, 2011

Safety of ultrasound-guided transrectal extended prostate biopsy in patients receiving low-dose aspirin. International Braz J Urol 36(3): 308-316, 2011

Comparison of dose-escalated, image-guided radiotherapy vs. dose-escalated, high-dose-rate brachytherapy boost in a modern cohort of intermediate-risk prostate cancer patients. BrachyTherapy 13(1): 59-67, 2014

Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: The William Beaumont Phase II dose-escalating trial. International Journal of Radiation Oncology Biology Physics 47(2): 343-352, May 1, 2000

The PICTURE study -- prostate imaging (multi-parametric MRI and Prostate HistoScanning™) compared to transperineal ultrasound guided biopsy for significant prostate cancer risk evaluation. Contemporary Clinical Trials 37(1): 69-83, 2014

Prostate cancer treatment with E-7869 in the TRAMP mouse. Proceedings of the American Association for Cancer Research Annual Meeting 40: 395, 1999

The short-term safety and immune responses of HER-2 DNA AutoVacTM in patients with HER-2 positive metastatic breast cancer Results from the first dose level of the phase I multi-dose trial. Breast Cancer Research & Treatment 76(Supplement 1): S80, 2002

MPC-7869 - Prostate cancer therapy - Treatment of Alzheimer's dementia. Drugs of the Future 31(1): 22-27, 2006

Clinical outcomes by relative docetaxel dose and dose intensity as chemotherapy for Japanese patients with castration-resistant prostate cancer: a retrospective multi-institutional collaborative study. International Journal of Clinical Oncology 19(1): 157-164, 2014

E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse. Cancer Research 60(8): 2203-2208, 2000

Safety and feasibility of image-guided robotic radiosurgery for patients with limited bone metastases of prostate cancer. Urologic Oncology 31(4): 455-460, 2013